These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 29599194)

  • 1. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.
    Kornberg MD; Bhargava P; Kim PM; Putluri V; Snowman AM; Putluri N; Calabresi PA; Snyder SH
    Science; 2018 Apr; 360(6387):449-453. PubMed ID: 29599194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Succination inactivates gasdermin D and blocks pyroptosis.
    Humphries F; Shmuel-Galia L; Ketelut-Carneiro N; Li S; Wang B; Nemmara VV; Wilson R; Jiang Z; Khalighinejad F; Muneeruddin K; Shaffer SA; Dutta R; Ionete C; Pesiridis S; Yang S; Thompson PR; Fitzgerald KA
    Science; 2020 Sep; 369(6511):1633-1637. PubMed ID: 32820063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects.
    Liao ST; Han C; Xu DQ; Fu XW; Wang JS; Kong LY
    Nat Commun; 2019 Nov; 10(1):5091. PubMed ID: 31704924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity.
    Liebmann M; Korn L; Janoschka C; Albrecht S; Lauks S; Herrmann AM; Schulte-Mecklenbeck A; Schwab N; Schneider-Hohendorf T; Eveslage M; Wildemann B; Luessi F; Schmidt S; Diebold M; Bittner S; Gross CC; Kovac S; Zipp F; Derfuss T; Kuhlmann T; König S; Meuth SG; Wiendl H; Klotz L
    Brain; 2021 Nov; 144(10):3126-3141. PubMed ID: 34849598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation by dimethyl fumarate treatment improves mouse sciatic nerve regeneration.
    Bombeiro AL; Pereira BTN; Bonfanti AP; Oliveira ALR
    Brain Res Bull; 2020 Jul; 160():24-32. PubMed ID: 32305403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis.
    Diebold M; Sievers C; Bantug G; Sanderson N; Kappos L; Kuhle J; Lindberg RLP; Derfuss T
    J Autoimmun; 2018 Jan; 86():39-50. PubMed ID: 28958667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial mechanisms of dimethyl fumarate in autoimmune uveitis: insights from single-cell RNA sequencing.
    Zhu L; Li H; Peng X; Li Z; Zhao S; Wu D; Chen J; Li S; Jia R; Li Z; Su W
    J Neuroinflammation; 2024 Apr; 21(1):112. PubMed ID: 38684986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis.
    Yadav SK; Soin D; Ito K; Dhib-Jalbut S
    J Mol Med (Berl); 2019 Apr; 97(4):463-472. PubMed ID: 30820593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis.
    Traub J; Traffehn S; Ochs J; Häusser-Kinzel S; Stephan S; Scannevin R; Brück W; Metz I; Weber MS
    Brain Pathol; 2019 Sep; 29(5):640-657. PubMed ID: 30706542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment.
    Cunill V; Massot M; Clemente A; Calles C; Andreu V; Núñez V; López-Gómez A; Díaz RM; Jiménez MLR; Pons J; Vives-Bauzà C; Ferrer JM
    Front Immunol; 2018; 9():1097. PubMed ID: 29896193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl fumarate: A review of preclinical efficacy in models of neurodegenerative diseases.
    Majkutewicz I
    Eur J Pharmacol; 2022 Jul; 926():175025. PubMed ID: 35569547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting immunometabolism as an anti-inflammatory strategy.
    Pålsson-McDermott EM; O'Neill LAJ
    Cell Res; 2020 Apr; 30(4):300-314. PubMed ID: 32132672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Immunometabolomic Interface Receptor Hydroxycarboxylic Acid Receptor 2 Mediates the Therapeutic Effects of Dimethyl Fumarate in Autoantibody-Induced Skin Inflammation.
    Wannick M; Assmann JC; Vielhauer JF; Offermanns S; Zillikens D; Sadik CD; Schwaninger M
    Front Immunol; 2018; 9():1890. PubMed ID: 30154797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the quantitative relationship between glycolysis and GAPDH in cancer cells exhibiting the Warburg effect.
    Zhu X; Jin C; Pan Q; Hu X
    J Biol Chem; 2021; 296():100369. PubMed ID: 33545174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein.
    Kastrati I; Siklos MI; Calderon-Gierszal EL; El-Shennawy L; Georgieva G; Thayer EN; Thatcher GR; Frasor J
    J Biol Chem; 2016 Feb; 291(7):3639-47. PubMed ID: 26683377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimethyl fumarate attenuates reactive microglia and long-term memory deficits following systemic immune challenge.
    Paraiso HC; Kuo PC; Curfman ET; Moon HJ; Sweazey RD; Yen JH; Chang FL; Yu IC
    J Neuroinflammation; 2018 Mar; 15(1):100. PubMed ID: 29598822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of three newly registered drugs for multiple sclerosis treatment.
    Kasarełło K; Cudnoch-Jędrzejewska A; Członkowski A; Mirowska-Guzel D
    Pharmacol Rep; 2017 Aug; 69(4):702-708. PubMed ID: 28550802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical guidelines for the use of dimethyl fumarate in relapsing-remitting multiple sclerosis].
    Alifirova VM; Boiko AN; Vlasov YV; Davydovskaya MV; Zakharova MN; Malkova NA; Popova EV; Sivertseva SA; Spirin NN; Khachanova NV; Shmidt ТЕ
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(1):97-102. PubMed ID: 28252608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimethyl fumarate: Regulatory effects on the immune system in the treatment of multiple sclerosis.
    Hosseini A; Masjedi A; Baradaran B; Hojjat-Farsangi M; Ghalamfarsa G; Anvari E; Jadidi-Niaragh F
    J Cell Physiol; 2019 Jul; 234(7):9943-9955. PubMed ID: 30536402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolved resistance to partial GAPDH inhibition results in loss of the Warburg effect and in a different state of glycolysis.
    Liberti MV; Allen AE; Ramesh V; Dai Z; Singleton KR; Guo Z; Liu JO; Wood KC; Locasale JW
    J Biol Chem; 2020 Jan; 295(1):111-124. PubMed ID: 31748414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.